| Individual Articles - Jul/Aug 2008 - Hormone Replacement Therapy |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: First Estriol, Then What?
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 284
|
Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
|
Jul/Aug 2008
Pg. 286-292
|
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
|
Jul/Aug 2008
Pg. 295-304
|
The Magic of Magnesium
Boomsma Diane
|
Jul/Aug 2008
Pg. 306-309
|
Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A, Mead Jay H
|
Jul/Aug 2008
Pg. 310-315
|
Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting
McElhiney Linda F
|
Jul/Aug 2008
Pg. 316-320
|
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists
Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane
|
Jul/Aug 2008
Pg. 321-327
|
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Jul/Aug 2008
Pg. 329-333
|
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization
Westrick Salisa C, Felkey Bill G
|
Jul/Aug 2008
Pg. 334-337
|
Marketing for Your Community
Storey Patricia L
|
Jul/Aug 2008
Pg. 338-339
|
Quality-Control Analytical Methods: Homogeneity of Dosing Forms
Kupiec Thomas C, Vu Nicole, Branscum David
|
Jul/Aug 2008
Pg. 340-343
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2008
Pg. 344-353
|
Calculations
Stockton Shelly J
|
Jul/Aug 2008
Pg. 354
|
Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 355
|
Silicone Cream
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 356
|
Sodium Chloride 0.9% Ointment
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 357
|
Squalene 0.2% Cream
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 358
|
Sucralfate and Hyaluronic Acid Ointment
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 359
|
Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 360
|
Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 361
|
Ultrasonic Adhesive Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 362
|
Vitamin A Suppository
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 363
|
Zirconium Oxide Lotion
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 364
|
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
|
Jul/Aug 2008
Pg. 365-367
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Jul/Aug 2008
Pg. 368-371
|
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
|
Jul/Aug 2008
Pg. 372-374
|
PostScription: It Is Not Just What You Say…But How You Say It!
Reed-Kane Dana
|
Jul/Aug 2008
Pg. 375
|
